Oculocutaneous albinism: epidemiology, genetics, skin manifestation, and psychosocial issues.
Ma EZ, Zhou AE, Hoegler KM, Khachemoune A.
Arch Dermatol Res. 2023 Mar;315(2):107-116. doi: 10.1007/s00403-022-02335-1. Epub 2022 Feb 25.
Oculocutaneous albinism.
Grønskov K, Ek J, Brondum-Nielsen K.
Orphanet J Rare Dis. 2007 Nov 2;2:43. doi: 10.1186/1750-1172-2-43.
Oculocutaneous Albinism.
Ye H, Mao K, Zhao P.
Asia Pac J Ophthalmol (Phila). 2023 Mar-Apr 01;12(2):268. doi: 10.1097/APO.0000000000000506. Epub 2022 Aug 18.
Oculocutaneous Albinism.
Bezerra Castaldelli G, Bezerra Castaldelli AJ, Anderson Castaldelli V.
JAMA Ophthalmol. 2021 Dec 1;139(12):e214068. doi: 10.1001/jamaophthalmol.2021.4068. Epub 2021 Dec 15.
Oculocutaneous albinism.
David CV.
Cutis. 2013 May;91(5):E1-4.
Oculocutaneous albinism.
Okulicz JF, Shah RS, Schwartz RA, Janniger CK.
J Eur Acad Dermatol Venereol. 2003 May;17(3):251-6. doi: 10.1046/j.1468-3083.2003.00767.x.
Oculocutaneous albinism.
Biswas S, Lloyd IC.
Arch Dis Child. 1999 Jun;80(6):565-9. doi: 10.1136/adc.80.6.565.
Comprehensive analysis of spectral distribution of a large cohort of Chinese patients with non-syndromic oculocutaneous albinism facilitates genetic diagnosis.
Zhong Z, Gu L, Zheng X, Ma N, Wu Z, Duan J, Zhang J, Chen J.
Pigment Cell Melanoma Res. 2019 Sep;32(5):672-686. doi: 10.1111/pcmr.12790. Epub 2019 May 29.
Current landscape of Oculocutaneous Albinism in Japan.
Okamura K, Suzuki T.
Pigment Cell Melanoma Res. 2021 Mar;34(2):190-203. doi: 10.1111/pcmr.12927. Epub 2020 Oct 7.
[Oculocutaneous and ocular albinism].
Kubasch AS, Meurer M.
Hautarzt. 2017 Nov;68(11):867-875. doi: 10.1007/s00105-017-4061-x.
